Latest AI and machine learning research in dementia for healthcare professionals.
BACKGROUND: Polygenic risk scores for Alzheimer's disease (AD-PRS) are widely used to estimate genetic susceptibility to AD, but their relationship with the rate of cognitive decline (CD) after clinical onset remains insufficiently characterized. OBJECTIVES: To examine the association between AD-PRS and longitudinal CD across the AD spectrum and to evaluate the predictive contribution of individua...
Hexafluoropropylene oxide-dimer acid (GenX or HFPO-DA) is a novel per- and polyfluoroalkyl substance developed as a replacement for legacy compounds, yet its potential neurotoxic effects remain poorly understood. In this study, we combined bibliometric profiling, in silico target prediction, in vivo behavioral assessments, single-nucleus RNA sequencing (snRNA-seq), network biology, machine learnin...
Alzheimer's disease (AD) is a neurodegenerative disorder, and mild cognitive impairment (MCI) represents a transitional stage between AD and cognitive...
BACKGROUND: Artificial intelligence (AI), extended reality (XR), and socially assistive robotics (SAR) are each advancing Alzheimer's disease (AD) res...
Alzheimer's disease (AD) and HIV-associated neurocognitive disorder (HAND) share progressive cognitive decline. Their common molecular mechanisms rema...
Somalia's fragile health system, strained by decades of conflict, climate shocks, and persistently low immunization coverage, remains dangerously vuln...
BackgroundApproximately half of people living with Alzheimer's disease and related dementias are undiagnosed.ObjectiveTo develop and validate algorith...
Alzheimer's disease (AD) is an irreversible neurodegenerative disorder where early diagnosis serves as the only viable window for effective interventi...
BackgroundAging causes declines in cognitive and motor functions, often manifested in altered gait. Dual-task gait is a sensitive marker for early fun...
Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by multifactorial pathology, including amyloid-β (Aβ) aggregation, ...
BackgroundTelomere dysfunction contributes to cellular aging and genome instability, but telomere-associated transcription in Alzheimer's disease (AD)...
BACKGROUND: Predicting cognitive decline as a continuum, from healthy age-related decline to mild cognitive impairment and dementia, enables more prec...
TAR DNA-binding protein 43 (TDP-43) inclusions are often associated with hyperphosphorylated tau, thus neurofibrillary tangles as the hallmark of Alzh...
BACKGROUND: Neuroimaging with [18F]FDG PET can support the diagnosis of Dementia with Lewy Bodies (DLB), but it remains unclear how genetic factors in...
BACKGROUND: Lewy body diseases (LBD) collectively share α-synuclein Lewy pathology, yet present wide clinical heterogeneity, with overlapping motor an...
Alzheimer's disease (AD) is a complex neurodegenerative disorder characterized by widespread dysregulation of gene expression and regulatory pathways....
Positron Emission Tomography (PET) is an important molecular imaging tool widely used in medicine. Traditional PET systems rely on complete detector r...
PURPOSE: QQ, a recently proposed oxygen extraction fraction (OEF) mapping technique combining quantitative susceptibility mapping (QSM) and quantitati...
BACKGROUND: Best practices in diagnosing autism spectrum disorder require an expert diagnostician to integrate multiple sources of information, includ...
Alzheimer's disease is a complex neurodegenerative disorder and the leading cause of dementia worldwide. Learning-based techniques applied to magnetic...